Matt Gethers/Articles to Read/Technical 13: Difference between revisions
Line 35: | Line 35: | ||
[http://www.ncbi.nlm.nih.gov/pubmed/21747695 Microfluidic technologies for synthetic biology.] | [http://www.ncbi.nlm.nih.gov/pubmed/21747695 Microfluidic technologies for synthetic biology.] | ||
[http://pubs.acs.org/doi/full/10.1021/ac200265g Use of Urine Volatile Organic Compounds To Discriminate Tuberculosis Patients from Healthy Subjects] |
Revision as of 10:15, 16 July 2011
Technical 13
Quantum Transport in Graphene Networks
Model for biological communication in a nanofabricated cell-mimic driven by stochastic resonance.
Multiple cell configuration electromagnetic vibration energy harvester
Detecting single viruses and nanoparticles using whispering gallery microlasers
Caveolar vesicles generate DNA damage and perpetuate cellular aging
Significant FRET between SWNT/DNA and Rare Earth Ions: A Signature of Their Spatial Correlations
Interactions between Magnetic Nanowires and Living Cells: Uptake, Toxicity, and Degradation
The Cat That Caught the Canary: What To Do with Single-Molecule Trapping
Metallization of Branched DNA Origami for Nanoelectronic Circuit Fabrication
Risk of collective failure provides an escape from the tragedy of the commons
Precise Manipulation of Chromosomes in vivo enables genome-wide codon replacement
A general strategy for the evolution of bond-forming enzymes using yeast display
Microfluidic technologies for synthetic biology.
Use of Urine Volatile Organic Compounds To Discriminate Tuberculosis Patients from Healthy Subjects